McDermott + Bull has successfully placed Mazi Kiani as Senior Vice President of Quality + Regulatory Affairs at Inari Medical. Mazi will be responsible for ensuring the highest standards of product quality and safety are achieved while navigating complex global regulatory landscapes. He will oversee all aspects of quality assurance, regulatory approvals, and compliance, ultimately contributing to Inari Medical’s growth and success.

Mazi brings over 18 years of quality and regulatory leadership experience in the medical device industry. Most recently, he served as Senior Vice President of Quality + Regulatory at iRhythm Technologies, Inc., where he played a large role in expanding the department and securing additional regulatory approvals. Previously, he was Senior Vice President of Quality + Regulatory at Siemens Healthineers, where he oversaw global quality and regulatory affairs across 120 countries. He began his career at Edwards LifeSciences before moving to Boston Scientific, where he managed numerous teams and enhanced the company’s product quality and compliance.   

Headquartered in Irvine, CA, Inari Medical Inc. (NARI) is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari’s current product offerings consist of two minimally-invasive, novel catheter-based mechanical thrombectomy systems, which are purpose-built for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, deep vein thrombosis, and pulmonary embolism. With a number of products under development, Inari remains focused on creating purpose-built systems for the treatment of a specific disease state. 

This executive search was completed by McDermott + Bull Co-Founder + Managing Partner Chris Bull, Partner Ken Dropiewski, Director Shelby Varon, and Research Associate Michael Matranga